Replicating viruses as selective cancer therapeutics

Molecular Medicine Today

Volumn 2, Issue 12, 1996, Pages 519-527

  Kirn, David H ^a   McCormick, Frank ^a  

^a ONYX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRIDAE; HERPES; NEWCASTLE DISEASE VIRUS; PARVOVIRUS; SIMPLEXVIRUS;

VIRUS PROTEIN;

ANIMAL; GENE VECTOR; HERPES SIMPLEX VIRUS; HUMAN; HUMAN ADENOVIRUS; IMMUNOLOGY; NEOPLASM; NEWCASTLE DISEASE PARAMYXOVIRUS; PARVOVIRUS; PHYSIOLOGY; REVIEW; VIRAL PHENOMENA AND FUNCTIONS; VIRUS REPLICATION;

ADENOVIRUSES, HUMAN; ANIMALS; GENETIC VECTORS; HUMANS; NEOPLASMS; NEWCASTLE DISEASE VIRUS; PARVOVIRUS; SIMPLEXVIRUS; VIRAL PHYSIOLOGY; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0030332823     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(97)81456-6     Document Type: Review

References (28)

1. Webb, H.E. and Smith, C.E. (1970) Viruses in the treatment of cancer, Lancet 658, 1206-1208
2. Smith, R. et al (1956) Studies on the use of viruses in the treatment of carcinoma of the cervix, Cancer 9, 1211-1218
3. Asada, T. (1974) Treatment of human cancer with mumps virus, Cancer 34, 1907-1928
4. Southam, C.M. and Moore, A.E. (1952) Clinical studies of viruses as antineo-plastic agents, with particular reference to Egypt 101 virus, Cancer 5, 1025-1034
5. Zinkernagel, R.M. (1996) Immunology taught by viruses, Science 271, 173-178
6. Russell, S.J., Hawkins, R.E. and Winter, G. (1993) Retroviral vectors displaying functional antibody fragments, Nucleic Acids Res. 21, 1081-1085
7. Han, X., Kasahara, N. and Kan, Y.W. (1995) Ligand-directed retroviral targeting of human breast cancer cells, Proc. Natl. Acad. Sci. U. S. A. 92, 9747-9751
8. Vile, R.G. et al. (1995) Tissue-specific gene expression from Mo-MLV retro-viral vectors with hybrid LTRs containing the murine tyrosinase enhancer/ promoter, Virology 214, 307-313
9. Martuza, R.L. et al. (1991) Experimental therapy of human glioma by means of a genetically engineered virus mutant, Science 252, 854-856
10. Mineta, T. et al. (1995) Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas, Nat. Med. 1, 938-943
11. Rommelaere, J. and Cornells, J.J. (1991) Antineoplastic activity of parvoviruses, J. Virol. Methods 33, 233-251
12. Op De Beeck, A. et al. (1995) The nonstructural proteins of the autonomous parvovirus minute virus of mice interfere with the cell cycle, inducing accumulation in G2, Cell Growth Differ. 6, 781-787
13. Gooding, L.R. (1994) Regulation of TNF-mediated cell death and inflammation by human adenoviruses, Infect. Agents Dis. 3, 106-115
14. Jia, W.W. et al. (1994) Selective destruction of gliomas in immunocompetent rats by thymidine kinase-defective herpes simplex virus type 1, J. Natl. Cancer Inst. 86, 1209-1215
15. Fearon, E.R. et al. (1988) Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene, Cancer Res. 48, 2975-2980
16. Hermiston, T.W. et al. (1993) Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes, J. Virol. 67, 5289-5298
17. Ginsberg, H.S. and Prince, G.A. (1994) The molecular basis of adenovirus pathogenesis, Infect. Agents Dis. 3, 1-8
18. Reichard, K.W. et al. (1992) Newcastle disease virus selectively kills human tumor cells, J. Surg. Res. 52, 448-453
19. Lorence, R.M. et al. (1994) Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy, J. Natl. Cancer Inst. 86, 1228-1233
20. Cassel, W.A., Murray, D.R. and Phillips, H.S. (1983) A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate, Cancer 52, 856-860
21. Van Pachterbeke, C. et al. (1993) Parvovirus H-1 inhibits growth of short-term tumor-derived but not normal mammary tissue cultures, Int. J. Cancer 55, 672-677
22. Dupont, F. et al. (1994) Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein, J. Virol. 68, 1397-1406
23. Barker, D.D. and Berk, A.J. (1987) Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection, Virology 156, 107-121
24. Bischoff, J. et al. (1996) An adenovirus mutant that replicates selectively in p53-deficient human tunor cells, Science 274, 373-376
25. Yang, Y. et al. (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy, Proc. Natl. Acad. Sci. U. S. A. 91, 4407-4411
26. Day, D.B., Zachariades, N.A. and Gooding, L.R. (1994) Cytolysis of adenovirus-infected murine fibroblasts by IFN-gamma-primed macrophages is TNF-and contact-dependent, Cell. Immunol. 157, 223-238
27. Mastrangelli, A. et al. (1996) Sero-swith adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype, Hum. Gene Ther. 7, 79-87
28. Yang, Y., Trinchieri, G. and Wilson, J.M. (1995) Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung, Nat. Med. 1, 890-893